Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 309 F0)
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2019
Price : $35 *
At a glance
- Drugs Vinflunine (Primary) ; Methotrexate
- Indications Head and neck cancer; Squamous cell cancer
- Focus Registrational; Therapeutic Use
- Sponsors Pierre Fabre
- 06 Feb 2019 This trial has been completed in Slovakia.
- 01 Feb 2019 Status changed from active, no longer recruiting to completed.
- 12 May 2018 This trial has been completed in Italy.